Statement Of Income And Retained Earnings

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7262351

Concept 2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2024-03-01 to
2025-02-28
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
2023-03-01 to
2024-02-29
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
13,707,000,000 JPY
18,895,000,000 JPY
13,167,000,000 JPY
10,704,000,000 JPY
Non-operating income
Non-operating income
2,890,000,000 JPY
5,365,000,000 JPY
6,605,000,000 JPY
3,601,000,000 JPY
Non-operating expenses
Non-operating expenses
85,000,000 JPY
251,000,000 JPY
123,000,000 JPY
80,000,000 JPY
Ordinary profit (loss)
16,511,000,000 JPY
24,010,000,000 JPY
19,649,000,000 JPY
14,226,000,000 JPY
Extraordinary income
Extraordinary income
5,044,000,000 JPY
5,044,000,000 JPY
391,000,000 JPY
391,000,000 JPY
Extraordinary losses
Extraordinary losses
365,000,000 JPY
367,000,000 JPY
854,000,000 JPY
852,000,000 JPY
Profit (loss) before income taxes
21,190,000,000 JPY
28,687,000,000 JPY
19,186,000,000 JPY
13,765,000,000 JPY
Income taxes - current
3,917,000,000 JPY
5,624,000,000 JPY
3,903,000,000 JPY
2,580,000,000 JPY
Income taxes - deferred
908,000,000 JPY
760,000,000 JPY
851,000,000 JPY
1,329,000,000 JPY
Profit (loss)
16,363,000,000 JPY
22,301,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
16,363,000,000 JPY
14,431,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY
9,855,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.